YONKERS, N.Y.--(BUSINESS WIRE)--Advanced Viral Research Corp. (OTCBB: ADVR), a research based biopharmaceutical company dedicated to the discovery and development of small molecule anti-cancer drugs, today announced the relocation of its corporate headquarters. In addition, the company has launched a new Web site at www.adviral.com.
